Background: Monitoring adverse events during chemotherapy by clinicians is a standard practice but clinicians mayreport fewer side-effects or lower symptom severity than patients. Our aim was to compare symptoms self-reported bypatients with symptoms registered by clinicians and nurses, to assess validity of a nurse reporting.Methods: From April to August 2007, a double-blind questionnaire with 13 common items graduated according tothe National Cancer Institute’s Common Terminology Criteria for Adverse Events was completed by clinicians andnurses for outpatients undergoing chemotherapy at our Medical Oncology Day Hospital Unit. Patients completeda modified questionnaire with simplified terms. They were requested to specify seriousness of sy...
International audienceThe National Cancer Institute Common Terminology Criteria for Adverse Events c...
Tracking symptoms related to treatment toxicity is standard practice in routine care and during clin...
Background Cancer treatments are associated with a multitude of adverse events (AEs)...
Toxicity of chemotherapy is a factor that most negatively affects the quality of life of cancer pati...
Background: The National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminol...
The National Cancer Institute’s Common Terminology Criteria for Adverse Events (NCI-CTCAE) reporting...
Toxicity of chemotherapy is a factor that most negatively aff ects the quality of life of cancer pa...
Purpose Adverse symptom event reporting is vital as part of clinical trials and drug labeling to ens...
Purpose Information about symptomatic toxicities of anticancer treatments is not based on direct re...
Purpose Information about symptomatic toxicities of anticancer treatments is not based on direct re...
PURPOSE: Developments in cancer treatments have resulted in increased survival of patients, but side...
BACKGROUND: Outcome indicators are increasingly advocated to demonstrate the impact of high-quality ...
Background: Chemotherapeutic drugs are commonly associated with various harmful consequences which c...
Symptomatic adverse event (AE) monitoring is essential in cancer clinical trials to assess patient s...
Clinicians can miss up to half of patients’ symptomatic toxicities in cancer clinical trials and rou...
International audienceThe National Cancer Institute Common Terminology Criteria for Adverse Events c...
Tracking symptoms related to treatment toxicity is standard practice in routine care and during clin...
Background Cancer treatments are associated with a multitude of adverse events (AEs)...
Toxicity of chemotherapy is a factor that most negatively affects the quality of life of cancer pati...
Background: The National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminol...
The National Cancer Institute’s Common Terminology Criteria for Adverse Events (NCI-CTCAE) reporting...
Toxicity of chemotherapy is a factor that most negatively aff ects the quality of life of cancer pa...
Purpose Adverse symptom event reporting is vital as part of clinical trials and drug labeling to ens...
Purpose Information about symptomatic toxicities of anticancer treatments is not based on direct re...
Purpose Information about symptomatic toxicities of anticancer treatments is not based on direct re...
PURPOSE: Developments in cancer treatments have resulted in increased survival of patients, but side...
BACKGROUND: Outcome indicators are increasingly advocated to demonstrate the impact of high-quality ...
Background: Chemotherapeutic drugs are commonly associated with various harmful consequences which c...
Symptomatic adverse event (AE) monitoring is essential in cancer clinical trials to assess patient s...
Clinicians can miss up to half of patients’ symptomatic toxicities in cancer clinical trials and rou...
International audienceThe National Cancer Institute Common Terminology Criteria for Adverse Events c...
Tracking symptoms related to treatment toxicity is standard practice in routine care and during clin...
Background Cancer treatments are associated with a multitude of adverse events (AEs)...